Explore Faster. Find What Matters.
Precision Explorer empowers researchers to identify patients, compare treatments, and analyze outcomes -- faster and with greater clarity than ever before.
Designed for HEOR, medical, and epidemiology teams, this GenAI-powered application removes the friction of legacy analytics processes. From dynamic cohort creation to instant outcomes analysis and citation-backed insights, users get answers in minutes – not weeks – no programming required. Precision Explorer empowers teams to collaborate faster, validate hypotheses sooner, and unlock continuous evidence generation across oncology.
Question-and-answer interface, no code required. Contextualizing complex concepts like event dates (e.g., metastasis, comorbidities, and adverse events) despite ambiguous or implicit references.
Share analyses, cohorts, reports, and personalized boards for key observations with colleagues for efficient collaboration.
Real-world outcome endpoints automatically generated for patient populations of interest.
Provide relevant source citations to increase transparency:
Standard of Care to Real-World Treatment Progression Comparison
Generate evidence, robust observational study design, analyzing data, sampling patients appropriately, ensuring it is free of bias & confounding, and sharing results that drive business direction and investment choice.
Results shared internally, in a peer reviewed publication, or a regulatory submission.
Focused on illuminating a specific area of investment such as disease burden, patient outcomes, success & effectiveness of a particular drug in market.
Generate evidence on economic value, outcomes, treatment impacts, and information to justify pricing and reimbursement.
Results shared internally, with payers/policy makers, or part of a regulatory submission.
Crucial to managing the economics of pharmaceutical development and commercialization.
Precision Explorer empowers researchers to identify patients, compare treatments, and analyze outcomes -- faster and with greater clarity than ever before.